tiprankstipranks
Trending News
More News >
InDex Pharmaceuticals Holding AB (SE:FLERIE)
:FLERIE
Sweden Market

InDex Pharmaceuticals Holding AB (FLERIE) Income Statement

Compare
0 Followers

InDex Pharmaceuticals Holding AB Income Statement

Last quarter (Q1 2025), InDex Pharmaceuticals Holding AB's total revenue was kr0.00, a decrease of -100.00% from the same quarter last year. In Q1, InDex Pharmaceuticals Holding AB's net income was kr-251.00M. See InDex Pharmaceuticals Holding AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 100.00Kkr 97.50Mkr 0.00kr 0.00kr 35.00K
Gross Profit
kr -41.60Mkr 93.35Mkr -1.07Mkr -1.25Mkr -57.73M
Operating Expenses
kr 275.10Mkr 200.71Mkr 150.05Mkr 114.38Mkr 41.36M
Depreciation and Amortization
kr 600.00Kkr 1.22Mkr 1.07Mkr 1.25Mkr 1.19M
EBITDA
kr -225.90Mkr -93.82Mkr -99.15Mkr -101.66Mkr -56.11M
Operating Income
kr -275.00Mkr -107.37Mkr -151.11Mkr -115.63Mkr -57.73M
Other Income/Expenses
kr 47.10Mkr 12.10Mkr 50.78Mkr 12.59Mkr 311.00K
Pretax Income
kr -227.90Mkr -95.27Mkr -100.33Mkr -103.04Mkr -57.42M
Net Income
kr -228.00Mkr -95.27Mkr -100.33Mkr -103.04Mkr -57.42M
Per Share Metrics
Basic EPS
kr -3.24kr -17.88kr -18.84kr -21.32kr -24.25
Diluted EPS
kr -3.24kr -17.88kr -18.84kr -21.32kr -24.25
Weighted Average Shares Outstanding
70.47M 53.27M 53.27M 48.34M 23.68M
Weighted Average Shares Outstanding (Diluted)
70.47M 53.27M 53.27M 48.34M 23.68M
Currency in SEK

InDex Pharmaceuticals Holding AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis